1. Home
  2. BLIN vs EDSA Comparison

BLIN vs EDSA Comparison

Compare BLIN & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

HOLD

Current Price

$0.73

Market Cap

9.2M

Sector

Technology

ML Signal

HOLD

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

HOLD

Current Price

$1.07

Market Cap

12.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLIN
EDSA
Founded
2000
2015
Country
United States
Canada
Employees
40
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
12.3M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
BLIN
EDSA
Price
$0.73
$1.07
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$4.62
$13.00
AVG Volume (30 Days)
54.6K
102.4K
Earning Date
02-12-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,383,000.00
N/A
Revenue This Year
$22.67
N/A
Revenue Next Year
$21.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.16
N/A
52 Week Low
$0.69
$0.94
52 Week High
$2.22
$4.49

Technical Indicators

Market Signals
Indicator
BLIN
EDSA
Relative Strength Index (RSI) 37.20 25.62
Support Level $0.73 $1.06
Resistance Level $0.84 $1.34
Average True Range (ATR) 0.05 0.13
MACD -0.00 -0.02
Stochastic Oscillator 27.16 19.96

Price Performance

Historical Comparison
BLIN
EDSA

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: